Encouraging data with Prosavin in Parkinson's
16th Nov 2006, 09:11 GMT
Preclinical efficacy results with gene-based product for Parkinson's disease, ProSavin, were presented at 14th Annual Congress of the European Society of Gene Therapy (ESGT) in Athens, November 2006